Skip to main content
SpringerLink
Log in

Preoperative Proton-MR Spectroscopy of Gliomas – Correlation with Quantitative Nuclear Morphology in Surgical Specimen

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

A comparison between data from proton-MR spectroscopy (1HMRS) and quantitative histomorphology of tumor cell nuclei in gliomas has not been reported up to now. Therefore, the question must be answered, if there are any significant correlations between histomorphology of gliomas and quantitative data from 1HMRS concerning tissue metabolites.

Surgical glioma specimen (glioblastomas, astrocytomas, oligodendrogliomas) from 46 patients with tumor grades II–IV according to WHO have been evaluated by means of a digital image analysis system using Ki-67-immunostained paraffin sections. Nuclear density, Ki-67-proliferation index, nuclear area and shape variables (roundness factor, Fourier-amplitudes) have been determined from 200 randomly selected tumor cell nuclei in each tumor specimen. These data have been correlated with preoperative data from 1HMRS.

A positive correlation between Fourier-amplitudes, choline peak and lipide peak was observed, as well as a negative correlation between these variables and the nuclear roundness factor. This result indicates higher choline and lipide peaks with increasing irregularity of nuclear outlines. Proliferation index Ki-67 was positively correlated with the lipide peak, nuclear density showed a positive correlation with the choline peak. Glioblastomas (n = 29) showed an additional positive correlation between mean nuclear size and total creatine. Anaplastic gliomas (n = 12) showed a positive correlation between lactate peak and the standard deviation of the nuclear roundness factor. Further multivariate analyses have shown, that for the present collective of 46 cases, histometric variables have a higher significance than spectroscopic data for the differentiation of the different tumor grades.

These results verify a significant correlation between preoperative data from 1HMRS and histomorphology of tumor cell nuclei in gliomas, supporting the biological significance of both histomorphometry and 1HMRS for the evaluation of these tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Graves EE, Nelson SJ, Vigneron DB, Chin C, Verhey L, McDermott M, Larson D, Sneed PK, Chang S, Prados MD, Lamborn K, Dillon WP: A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas. Neurosurgery 46: 319–328, 2000

    Google Scholar 

  2. Gupta RK, Cloughesy TF, Sinha U, Garakian J, Lazareff J, Rubino G, Rubino L, Becker DP, Vinters HV, Alger JR: Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neuro-Oncol 50: 215–226, 2000

    Google Scholar 

  3. Norfray JF, Tomita T, Byrd SE, Ross BD, Berger PA, Miller RS: Clinical impact of MR spectroscopy when MR imaging is indeterminate for pediatric brain tumors. Am J Radiol 173: 119–125, 1999

    Google Scholar 

  4. Kleihues P, Cavenee WK: Pathology & Genetics - Tumors of the Nervous System. IARC Press, Lyon, 2000, pp 27–39

    Google Scholar 

  5. Bottomley PA: Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 508: 333–348, 1987

    Google Scholar 

  6. Haase A, Frahm J, H¨anicke W, Matthei D: 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 30: 341–344, 1985

    Google Scholar 

  7. MRUI Home Page. See: http://www.mrui.uab.es/mrui/ mruiHomePage.html

  8. De Beer, Van den Boogaart A, van Ormondt D, Pijnappel WW, den Hollander JA, Marien AJ: Application of time domain fitting in the quantification of in vivo 1H spectroscopic imaging data sets. NMR Biomed 5: 171–178, 1992

    Google Scholar 

  9. Van der Veen JWC, De Beer PR, Luyten PR, Van Ormondt D: Accurate quantification of in vivo 31P-NMR signals using the variable projection method and prior knowledge. Magn Reson Med 6: 92–98, 1988

    Google Scholar 

  10. Petrow OAC, Spencer DD, Alger JR, Prichard JW: High field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy. Neurology 39: 1197–1202, 1989

    Google Scholar 

  11. Klunk WE, Xu CJ, Panchalingham K, Mc Clure RJ, Pettegrew JW: Analysis of magnetic resonance spectra by mole percent: comparison of absolute units. Neurobiol Aging 15: 133–140, 1994

    Google Scholar 

  12. Magnetom Vision Application-Manual, Numaris Version 31C. Siemens AG, Erlangen, Germany, 1999, pp 3–40

    Google Scholar 

  13. Nafe R, Schlote W, Schneider B: Planimetric characterization of tumor cell nuclei in astrocytic tumors - comparison of different tumor grades according to the WHO-classification. Electron J Pathol 6, 004–01.txt, 2000

    Google Scholar 

  14. Nafe R, Glienke W, Schlote W, Schneider B: EGFR geneamplification in glioblastomas - is there a relation with morphology of tumor cell nuclei and proliferative activity? Anal Quant Cytol Histol 23: 135–143, 2001

    Google Scholar 

  15. Nafe R, Schlote W, Schneider B: Data analysis for comparative histometry in pathology - I. Classification procedures and other statistical methods. Electron J Pathol 6, 002–03.txt, 2000

    Google Scholar 

  16. Hagberg G, Burlina AP, Mader I, Roser W, Radue EW, Seelig J: In vivo protonMRspectroscopy of human gliomas: definition of metabolic coordinates for multidimensional classification. MRM 34: 242–252, 1995

    Google Scholar 

  17. Lin A, Bluml S, Mamelak AN: Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors. J Neuro-Oncol 45: 69–81, 1999

    Google Scholar 

  18. McBride DQ, Miller BL, Nikas DL, Buchthal S, Chang L, Chiang F, Booth RA: Analysis of brain tumors using 1H magnetic resonance spectroscopy. Surg Neurol 44: 137–144, 1995

    Google Scholar 

  19. Usenius JP, Vainio P, Hernesniemi J, Kauppinen RA: Choline-containing compounds in human astrocytomas studied by 1H-NMR spectroscopy in vivo and in vitro. J Neurochem 63: 1538–1543, 1994

    Google Scholar 

  20. Byrd SE, Tomita T, Palka PS, Darling CF, Norfray JP, Fan J: Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors, part II: clinical analysis. J Natl Med Assoc 88: 717–723, 1996

    Google Scholar 

  21. Falini A, Calabrese G, Origgi D, Lipari S, Triulzi F, Losa M, Scotti G: Proton magnetic resonance spectroscopy and intracranial tumours: clinical perspectives. J Neurol 243: 706–714, 1996

    Google Scholar 

  22. Meyerand ME, Pipas JM, Mamourian A, Tosteson TD, Dunn JF: Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy. Am J Neuroradiol 20: 117–123, 1999

    Google Scholar 

  23. Negendank WG, Sauter R, Brown TR, Evelhoch JL, Falini A, Gotsis ED, Heerschap A, Kamada K, Lee BCP, Mengeot MM, Moser E, Padavic-Shaller KA, Sanders JA, Spraggins TA, Stillman AE, Terwey B, Vogl TJ, Wicklow K, Zimmerman RA: Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 84: 449–458, 1996

    Google Scholar 

  24. Shimizu H, Kumabe T, Tominaga T, Kayama T, Hara K, Ono Y, Sato K, Arai N, Fujiwara S, Yoshimoto T: Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. Am J Neuroradiol 17: 737–747, 1996

    Google Scholar 

  25. Castillo M, Smith JK, Kwock L: Correlation of myoinositol levels and grading of cerebral astrocytomas. Am J Neuroradiol 21: 1645–1649, 2000

    Google Scholar 

  26. Carpinelli G, Carapella CM, Palombi L, Raus L, Caroli F, Podo F: Differentiation of glioblastoma multiforme from astrocytomas by in vitro 1H MRS analysis of human brain tumors. Anticancer Res 16: 1559–1564, 1996

    Google Scholar 

  27. Carapella CM, Carpinelli G, Knijn A, Raus L, Caroli F, Podo F: Potential role of in vitro 1H-magnetic resonance spectroscopy in the definition of malignancy grading of human neuroepithelial brain tumours. Acta Neurochir (Suppl) 68: 127–132, 1997

    Google Scholar 

  28. Go KG, Kamman RL, Pruim J, Hew JM, Vaalburg W, Paans AMJ, Mooyaart EL, Heesters MAAM, Lopes da Silva FH: On the principles underlying the diagnosis of brain tumours - A survey article. Acta Neurochir (Wien) 135: 1–11, 1995

    Google Scholar 

  29. Bendszus M, Warmuth-Metz M, Klein R, Burger R, Schichor C, Tonn JC, Solymosi L: MR spectroscopy in gliomatosis cerebri. Am J Neuroradiol 21: 375–380, 2000

    Google Scholar 

  30. Girard N, Wang ZJ, Erbetta A, Sutton LN, Phillips PC, Rorke LB, Zimmerman RA: Prognostic value of proton MRspectroscopy of cerebral hemisphere tumors in children. Neuroradiology 40: 121–125, 1998

    Google Scholar 

  31. Lazareff JA, Bockhorst KHJ, Curran J, Olmstead C, Alger JR: Pediatric low-grade gliomas: prognosis with proton magnetic resonance spectroscopic imaging. Neurosurgery 43: 809–818, 1998

    Google Scholar 

  32. Lazareff JA, Gupta RK, Alger JR: Variation of posttreatment H-MRSI choline signal intensity in pediatric gliomas. J Neuro-Oncol 41: 291–298, 1999

    Google Scholar 

  33. Norfray JF, Darling C, Byrd S, Ross BD, Schwalm C, Miller R, Tomita T: Short TE proton MRS and neurofibromatosis type 1 intracranial lesions. J Comput Assist Tomogr 23: 994–1003, 1999

    Google Scholar 

  34. Tedeschi G, Lundbom N, Raman R, Bonavita S, Duyn JH, Alger JR, diChiro G: Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87: 516–524, 1997

    Google Scholar 

  35. Tamiya T, Kinoshita K, Ono Y, Matsumoto K, Furuta T, Ohmoto T: Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas. Neuroradiology 42: 333–338, 2000

    Google Scholar 

  36. Parivar F, Hricak H, Shinohara K, Kurhanewicz J, Vigneron DB, Nelson SJ, Carroll PR: Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging and three-dimensional proton magnetic resonance spectroscopy. Urology 48: 594–599, 1996

    Google Scholar 

  37. Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu Y, Wefer J, Mueller-Lisse U, Carroll PR, Kurhanewicz J: Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 164: 400–404, 2000

    Google Scholar 

  38. Cheng LL, Ma MJ, Becerra L, Ptak T, Tracey I, Lackner A, Gonz´alez RG: Quantitative neuropathology by high-resolution magic angle spinning proton magnetic resonance spectroscopy. Proc Natl Acad Sci USA 94: 6408–6413, 1997

    Google Scholar 

  39. Woermann FG, McLean MA, Bartlett PA, Parker GJ, Barker GJ, Duncan JS: Short echo time single-voxel 1H magnetic resonance spectroscopy in magnetic resonance imaging - negative temporal lobe epilepsy: different biochemical profile compared with hippocampal sclerosis. Ann Neurol 45: 369–376, 1999

    Google Scholar 

  40. Gerdes J, Lemke H, B aisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710–1715, 1984.

    Google Scholar 

  41. Shimizu H, Kumabe T, Shirane R, Yoshimoto T: Correlation between choline level measured by protonMRspectroscopy and Ki-67 labelling index in gliomas. Am J Neuroradiol 21: 659–665, 2000

    Google Scholar 

  42. Kuesel AC, Sutherland GR, Halliday W, Smith IC: 1H-MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue. NMR Biomed 7: 149–155, 1994

    Google Scholar 

  43. Nafe R, Schlote W, Schneider B: Shape analysis of tumor cell nuclei in ependymomas by means of Fourier-analysis. Anal Quant Cytol Histol 22: 475–482, 2000

    Google Scholar 

  44. Bhakoo KK, Williams SR, Florian CL, Land H, Noble MD: Immortalization and transformation are associated with specific alterations in choline metabolism. Cancer Res 56: 4630–4635, 1996

    Google Scholar 

  45. Chang L, McBride D, Miller BL, Cornford M, Booth RA, Buchthal SD, Ernst TM, Jenden DJ: Localized in vivo 1H magnetic resonance spectroscopy and in vitro analyses of heterogeneous brain tumors. J Neuroimaging 5: 157–163, 1995

    Google Scholar 

  46. Miller BL: A review of chemical issues in 1H-NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 4: 47–52, 1991

    Google Scholar 

  47. Miller BL, Chang L, Booth RA, Ernst T, Cornford M, Nikas D, McBride D, Jenden DJ: In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci 58: 1929-1935, 1996

    Google Scholar 

  48. Aiken NR, Gillies RJ: Phosphomonoester metabolism as a function of cell proliferative status and exogeneous precursors. Anticancer Res 16: 1393–1397, 1996

    Google Scholar 

  49. Demaerel P, Johannik K, vanHecke P, vanOngeval C, Verellen S, Marchal G, Wilms G, Plets C, Goffin J, van Calenbergh F, Lammens M, Baert AL: Localized 1H-NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr 15: 67–76, 1991

    Google Scholar 

  50. Luyten PR, Marien AJ, Heindel W, vanGerwen PH, Herholz K, denHollander JA, Friedmann G, Heiss WD: Metabolic imaging of patients with intracranial tumors: 1H-MR spectroscopic imaging and PET. Radiology 176: 791–799, 1990

    Google Scholar 

  51. Miller BL, McBride D, Riedy G, Caron M, Lipcamon J, O'Brien D: Changes in brain choline in 1H-MR spectroscopy. Bull Clin Neurosci 55: 115–122, 1990

    Google Scholar 

  52. Alger JR, Frank JA, Bizzi A, Fulham MJ, DeSouza BX, Duhaney MO, Inscoe SW, Black JL, vanZijl PCM, Moonen CTW, DiChiro G: Metabolism of human gliomas: assessment with 1H-MR spectroscopy and F-18-Fluorodeoxyglucose PET. Radiology 177: 633–641, 1990

    Google Scholar 

  53. McCoy CL, McIntyre DJO, Robinson SP, Aboagye EO, Griffith JR: Magnetic resonance spectroscopy and imaging methods for measuring tumor and tissue oxygenation. Br J Cancer (Suppl) 74: 226–231, 1996

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuroradiology, Clinics of Johann Wolfgang Goethe-University, Frankfurt/Main, Germany

    Reinhold Nafe, Sebastian Herminghaus, Peter Raab, Sabine Wagner, Ulrich Pilatus, Friedhelm Zanella & Heinrich Lanfermann

  2. Department of Biometrics, Medical School, Hannover, Germany

    Berthold Schneider

  3. Department of Neuropathology (Edinger Institute), Clinics of Johann Wolfgang Goethe-University, Frankfurt/Main, Germany

    Wolfgang Schlote

Authors
  1. Reinhold Nafe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sebastian Herminghaus
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Raab
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sabine Wagner
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ulrich Pilatus
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Berthold Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wolfgang Schlote
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Friedhelm Zanella
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Heinrich Lanfermann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nafe, R., Herminghaus, S., Raab, P. et al. Preoperative Proton-MR Spectroscopy of Gliomas – Correlation with Quantitative Nuclear Morphology in Surgical Specimen. J Neurooncol 63, 233–245 (2003). https://doi.org/10.1023/A:1024249232454

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024249232454

Search

Navigation